Related Experiment Videos
Fatal familial insomnia: clinical features and molecular genetics
P Cortelli1, P Gambetti, P Montagna
1Institute of Clinical Neurology, University of Bologna, Italy.
Abstract:
Fatal familial insomnia (FFI) is an autosomal dominant prion disease clinically characterized by inattention, sleep loss, dysautonomia, and motor signs and pathologically characterized by a preferential thalamic degeneration. FFI is linked to a missense mutation at codon 178 of the prion protein gene, PRNP, coupled with the presence of the codon methionine at position 129, the locus of a methionine-valine polymorphism. Homozygotes at codon 129, expressing methionine also in the nonmutated allele, have a shorter disease course (often less than 1 year), prominent sleep and autonomic disturbances at disease onset, and pathology restricted to the thalamus. Heterozygotes at codon 129, expressing valine in the nonmutated allele, have a longer disease course (often longer than 1 year), ataxia and dysarthria at disease onset, and lesions widespread to cerebral cortex. Both in the thalamus and in the cortex, the limbic structures are those most consistently and severely involved: the anterior ventral and mediodorsal thalamic nuclei, the cingulate gyrus, and the orbitofrontal cortex. FFI is thus a prion disease selectively damaging the thalamocortical limbic structures. Loss of sleep, sympathetic hyperactivity, and flattening of vegetative and hormonal circadian oscillations characterize FFI and result from a homeostatic imbalance caused by the interruption of the thalamocortical limbic circuits, the phylogenetically most advanced structures involved in the control of the sleep-wake cycle and the body's homeostasis. The selective atrophy of the limbic thalamus that characterizes FFI might be due to the binding of FFI toxic PrP or PrPres to specific receptors on thalamolimbic neurons.
Insights
Fatal familial insomnia (FFI) is a prion disease causing severe sleep loss and autonomic dysfunction due to thalamic degeneration. Genetic factors influence FFI
Area of Science:
- Neuroscience
- Genetics
- Pathology
Background:
- Fatal familial insomnia (FFI) is a rare, autosomal dominant prion disease.
- It is characterized by progressive insomnia, autonomic dysfunction, and motor deficits.
- Pathologically, FFI involves selective degeneration of thalamic nuclei.
Purpose of the Study:
- To elucidate the genetic basis and clinicopathological features of Fatal familial insomnia.
- To understand the relationship between PRNP gene mutations, codon 129 polymorphism, and disease phenotype.
- To investigate the structural and functional consequences of thalamocortical limbic circuit damage in FFI.
Main Methods:
- Genetic analysis of the prion protein gene (PRNP) including codon 178 mutation and codon 129 polymorphism.
- Clinical assessment of patient symptoms, including sleep, autonomic, and motor functions.
- Pathological examination of brain tissue to determine the distribution and severity of lesions.
Main Results:
- FFI is linked to a PRNP missense mutation at codon 178, particularly when associated with methionine at codon 129.
- Homozygosity at codon 129 (Met/Met) leads to a shorter disease course, prominent sleep/autonomic disturbances, and thalamus-restricted pathology.
- Heterozygosity at codon 129 (Met/Val) results in a longer disease course, ataxia/dysarthria, and widespread lesions including the cerebral cortex.
- Limbic structures (thalamus, cingulate gyrus, orbitofrontal cortex) are consistently and severely affected.
- FFI selectively damages thalamocortical limbic structures, disrupting sleep-wake cycle and homeostasis.
Conclusions:
- FFI is a prion disease characterized by selective thalamocortical limbic degeneration.
- The PRNP codon 129 polymorphism significantly modulates the clinical and pathological phenotype of FFI.
- Damage to thalamocortical limbic circuits underlies the characteristic sleep, autonomic, and homeostatic disturbances in FFI.